Abstract:Objective To evaluate the pharmacokinetic profiles and rel-ative bioavailability of fluvastatin in healthy Chinese subjects following o-ral administration of single and multiple doses of prolonged -extended re-lease ( XL) fluvastatin sodium tablets or immediate -release ( IR) cap-sules.Methods This was an open -label, randomized, two-period, two-treatment, crossover study.Twenty -four subjects were orally ad-ministered fluvastatin sodium XL tablet 80 mg qd or IR capsule 40 mg bid for 7 days.The serum concentrations of fluvastatin were determined by LC-MS/MS.The pharmacokinetic parameters and the relative bioavail-ability were calculated by non -compartmental analysis ( NCA ) using WinNonlin program.The statistical comparison of the pharmacokinetic parameters between these two formulations was conducted using SPSS 18.0.Results The pharmacokinetic parameters of fluvastatin after single oral dose of fluvastatin sodium XL tablet 80 mg qd and fluvastatin IR capsule 40 mg bid were as follows:Cmax were (79.00 ±36.83 ), (439.80 ±199.35 ) ng· mL-1;tmax were 3.00,0.50 h;t1/2 were (5.39 ± 2.89), (1.88 ±0.50) h;AUC0-24 h were (347.82 ±134.19 ), (815.25 ±326.30 ) ng· h· mL-1;AUC0-∞ were (342.34 ±146.05), (792.32 ±294.33) ng· h· mL -1, respectively.The pharmacokinetic parameters of fluvastatin after multiple oral doses of fluvastatin sodium XL tablet 80 mg qd and IR capsule 40 mg bid were as follows:Cmax,s were (96.85 ±59.38), (526.54 ±228.08) ng· mL-1;Cav,sswere (18.04 ±8.29), (63.39 ±29.02) ng· mL-1;tmax,ss were 3.00, 0.50 h;t1/2 were (5.13 ±2.69 ), (1.74 ±0.26 ) h; AUCtau,ss were (435.46 ±213.14 ), (1194.11 ± 582.51 ) ng· h· mL-1 , respectively.The relative bioavailabilities of fluvastatin sodium XL tablet 80 mg to IR capsule 40 mg were 43.94%and 38.67%on day 1 ( after single dose administration ) and day 7 ( after reaching steady state ) , respectively.Mild adverse events occurred in this trial.Conclusion Comparing with fluvastatin sodium IR capsues , Cmax of fluvastatin sodium XL tablet was reduced and tmax was prolonged.There was no significant accumulation for XL and IR formulations after multiple doses.

Pharmacokinetics of rosuvastatin calcium tablets in Chinese healthy volunteers after a single oral dose administration

Pharmacokinetics and Safety of Pitavastatin Calcium Tablets in Chinese Healthy Volunteers after a Single Oral Dose Administration

Clinical Study for Dose-Effect and Safety of Rosuvastatin in Patients with Primary Hypercholesterolemia

Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study.

Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single‐dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics of Escitalopram in Healthy Volunteers

Effects of Food and Gender on Pharmacokinetics of Rosuvastatin in a Chinese Population Based on 4 Bioequivalence Studies

Study of Pharmacokinetics of Vardenafil Tablets in Chinese Male Healthy Volunteers

Pharmacokinetics of Compound Telmisartan Tablets in Chinese Healthy Volunteers

Pharmacokinetics of compound famotidine chewing tablets in Chinese healthy volunteers after a single oral dose administration

Pharmacokinetic and Relative Bioavailability of Losartan Potassium Tablet in Chinese Healthy Volunteers

The Effect of Herbal Medicine Baicalin on Pharmacokinetics of Rosuvastatin, Substrate of Organic Anion‐transporting Polypeptide 1B1

Pharmacokinetics of escitalopram in Chinese healthy volunteers after oral administration of different doses

Pharmacokinetic study of amlodipine besylate and folic acid tablet in Chinese healthy volunteers

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Study on pharmacokinetics of fluvastatin in healthy subjects after single and multiple doses of porolonged-extended release fluvastatin and immediate-release fluvastatin

Pharmacokinetics of a metoprolol prolonged-release tablet in Chinese healthy volunteers

Pharmacokinetics of escitalopram in Chinese healthy volunteers after single and multiple oral administration

Bioequivalence of Rosiglitazone Tartrate Tables and Rosiglitazone Maleate Tables in Healthy Volunteers